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The deltaretroviruses human T cell lymphotropic virus type 1 (HTLV-1) and human T cell
lymphotropic virus type 2 (HTLV-2) have long been believed to differ from retroviruses in
other genera by their mode of transmission. While other retroviruses were thought to pri-
marily spread by producing cell-free particles that diffuse through extracellular ﬂuids prior
to binding to and infecting target cells, HTLV-1 and HTLV-2 were believed to transmit the
virus solely by cell–cell interactions. This difference in transmission was believed to reﬂect
the fact that, relative to other retroviruses, the cell-free virions produced by HTLV-infected
cells are very poorly infectious. Since HTLV-1 and HTLV-2 are primarily found in T cells in
the peripheral blood, spread of these viruses was believed to occur between infected and
uninfected T cells, although little was known about the cellular and viral proteins involved
in this interaction. Recent studies have revealed that the method of transmission of HTLV
is not unique: other retroviruses including human immunodeﬁciency virus (HIV) are also
transmitted from cell-to-cell, and this method is dramatically more efﬁcient than cell-free
transmission. Moreover, cell–cell transmission of HTLV-1, as well as HIV, can occur follow-
ing interactions between dendritic cells andT cells, as well as betweenT cells. Conversely,
other studies have shown that cell-free HTLV-1 is not as poorly infectious as previously
thought, since it is capable of infecting certain cell types. Here we summarize the recent
insights about the mechanisms of cell–cell transmission of HTLV-1 and other retroviruses.
We also review in vitro and in vivo studies of infection and discuss how these ﬁnding may
relate to the spread of HTLV-1 between individuals.
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INTRODUCTION
Human T cell lymphotropic virus type 1 (HTLV-1) was the
ﬁrst pathogenic retrovirus discovered in humans (Poiesz et al.,
1980). This virus is the only human retrovirus known to be the
causal agent of a cancer, a neoplasia called adult T cell leukemia
(ATL; Yoshida et al., 1982, 1984). HTLV-1 is also associated with
several inﬂammatory disorders, primarily a progressive neurologi-
cal disease named HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP; Gessain et al., 1985; Osame et al., 1986).
The closely related retrovirus human T cell leukemia virus type
2 (HTLV-2) does not cause leukemia, although some infected
individuals develop mild lymphocytosis and, occasionally, neuro-
logic symptoms (Hjelle et al., 1992; Dooneief et al., 1996; Feuer
and Green, 2005; Biswas et al., 2009). In the peripheral blood
of infected individuals, both HTLV-1 and HTLV-2 are primar-
ily found in T cells, and both viruses can immortalize T cells in
culture (reviewed in Feuer and Green, 2005). ATL is a malignancy
of CD4+ T cells, andHTLV-1 primarily infects CD4+ T cells, while
HTLV-2 primarily infects CD8+T cells (Kira et al., 1991; Lal et al.,
1995; Wu et al., 1996; Manns et al., 1999; Nagai et al., 2001; Mur-
phy et al., 2004). Dendritic cells (DCs), B cells, andmonocytes can
also be infected in individuals with HTLV (Macatonia et al., 1992;
Koyanagi et al., 1993).
Like other retroviruses, HTLV-1 and HTLV-2 enter target
cells following speciﬁc interactions between the viral envelope
glycoprotein (Env) and cellular receptors. Efﬁcient entry of HTLV-
1 has been shown to involve three distinct molecules: heparan
sulfate proteoglycans (HSPGs) and Neuropilin 1 (NRP-1) for the
initial binding to the cell, and glucose transporter 1 (GLUT1)
for entry (Manel et al., 2003; Jones et al., 2005; Ghez et al., 2006;
Lambert et al., 2009). HTLV-2 binding and entry also involves
NRP-1 and GLUT1, but differs from HTLV-1 in that it does not
require HSPG. The studies identifying the HTLV receptors have
recently been extensively reviewed (Ghez et al., 2010; Ilinskaya
et al., 2010; Jones et al., 2011; Hoshino, 2012) and thus will not be
detailed here.
For many years, HTLV-1 and HTLV-2 were believed to differ
from retroviruses in other genera in their mode of transmission.
For the other retroviruses, viral spread was thought to require the
production of cell-free viral particles that diffuse through extra-
cellular ﬂuids and subsequently bind to, enter, and infect target
cells. For HTLV-1 and HTLV-2, it was believed that the cell-free
virus was poorly infectious, and that the viruses could only be efﬁ-
ciently spread by direct contact between infected cells and target
cells (cell–cell transmission).
The belief that HTLV-1 is poorly infectious as a cell-free
particle originated soon after its discovery and was based on
both in vivo and in vitro observations. Studies of transfusion
suggested that cell–cell contact is required for HTLV-1 transmis-
sion: although a high percentage of individuals receiving cellular
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blood components (whole blood, red blood cells, or platelets)
from HTLV-1- or HTLV-2-infected individuals become infected
with the virus, the recipients of non-cellular blood products
(plasma fraction or plasma derivatives) from infected individu-
als do not become infected (Maeda et al., 1984; Miyamoto et al.,
1984; Jason et al., 1985; Lairmore et al., 1989). In one study
directly comparing transmission following transfusion of plasma
from individuals with different human retroviruses, seroconver-
sion occurred in 89% of the individuals who received plasma
from HIV-1 infected individuals, but in none of the individuals
who received plasma from individuals with HTLV-1 or HTLV-2
(Donegan et al., 1994).
In vitro experiments supported the notion that the cell-free
virus is poorly infectious. Although in the peripheral blood the
virus is primarily found in T cells, early studies showed that cell-
free HTLV-1 and HTLV-2 do not efﬁciently infect or transform
primary T cells isolated from the peripheral blood in vitro. In
contrast, primaryT cells can become infected and transformed fol-
lowing coculturewith eitherHTLV-1-infected orHTLV-2-infected
cell lines (Yamamoto et al., 1982; Popovic et al., 1983; Green and
Chen, 1990).
However, other in vitro studies showed that cell-free HTLV-
1 is not completely non-infectious. Early studies reported rare
infection of T cells (de Rossi et al., 1985) and non-lymphoid cells
(Clapham et al., 1983) by cell-free virus. Later studies using more
sensitive assays reported that a number of T and B cell lines (Fan
et al., 1992; Agadjanyan et al., 1994; Jinno et al., 1999), as well as
cell lines of non-lymphoid origin (Graziani et al., 1993; Haraguchi
et al., 1994), could be infected following exposure to cell-free virus,
although at a very low level. More recent studies with DCs have
conﬁrmed and extended the notion that cell-free HTLV-1 can be
infectious. Several groups have demonstrated that the primary
DCs, unlike T cells, are routinely infected after exposure to cell-
free virus (Jones et al., 2008; Jain et al., 2009; Lambert et al., 2009;
Valeri et al., 2010). In addition, in contrast to what occurs in cul-
tures of puriﬁed T cells, T cells cocultured with DCs routinely
become infected after the addition of cell-free virus. Further stud-
ies showed that when DCs are exposed to cell-free virus, they
rapidly transmit the virus to T cells. These observations suggest
that there may be blocks to infection after the cell-free particle
binds to T cells that are not present when the virus is presented by
DC cells to T cells, or that interacting with the DCs alters the virus
in a way that allows it to infect T cells.
As described above, several early studies showed that the plasma
from HTLV-1- and HTLV-2-infected individuals does not infect
recipients of transfusions. Originally, these studies were inter-
preted as reﬂecting the fact that cell-free HTLV-1 and HTLV-2
virions in the blood are far less infectious and/or more labile
than HIV-1 virions. However, later studies revealed that cell-free
viral particles are only rarely be detected in plasma or serum from
HTLV-1- or HTLV-2-infected individuals. Other studies revealed
that, even in individualswith a high percentage of PBMCs contain-
ing integrated HTLV-1 genomic DNA, little or no viral mRNAs or
proteins are detected in PBMC immediately after isolation (Ges-
sain et al., 1991; Richardson et al., 1997; Moritoyo et al., 1999).
These observations indicate that the lack of infection through acel-
lular blood products is due to the lack of detectable levels of virus
in peripheral blood, and thus does not support the notion that
HTLV-1 particles are inherently non-infectious.
The lack of viremia in individuals with HTLV-1 is in sharp con-
trast to the high levels of viremia and active replication found in
HIV-1-infected individuals. Indeed, the method of persistence of
HTLV-1 in infected individuals appears to be very different from
that of HIV-1. The peripheral blood of HTLV-1-infected individu-
als contains clones of large numbers of infected cells with the same
integration site (Wattel et al., 1995; Leclercq et al., 1998; Zane et al.,
2009), indicating that they are derived from a single infected cell.
Further studies revealed that speciﬁc clones can persist over years
in a given individual (Cavrois et al., 1996; Etoh et al., 1997; Cavrois
et al., 1998). A recent characterization of infected cells using high-
throughput methods revealed that, in a typical HTLV-1-infected
individual without ATL, there are between 500 and 5000 clones
and the majority of these clones are maintained over a period of
years (Gillet et al., 2011).
The presence of these clones indicates that, rather than spread-
ing from cell-to-cell, HTLV-1 persists in individuals primarily by
mitotic replication of infected cells. Consistent with this, the per-
centage of infected cells (referred to as the HTLV-1 proviral load)
remains stable within an individual over time. Moreover, unlike
HIV-1, the HTLV-1 genome shows very little variation within an
individual, consistent with it being replicated by cellular DNA
polymerase during division of infected cells rather than the more
error-prone reverse transcriptase. Taken together, these observa-
tions have lead to the belief that HTLV-1 persists in two stages
in an individual. Soon after an individual is exposed to the virus,
HTLV-1 spreads from cell-to-cell. Later, during the chronic stage
of infection, the virus persists via clonal expansion, through repli-
cation of the provirus integrated into the host cell genome during
the division of infected cells.
Ten years ago, little was known about the mechanism of
the cell–cell transmission of HTLV-1. Since that time, imaging
studies along with in vitro studies of infection have provided
insight into the interactions between cells required for infection
of T cells by HTLV-1. During this time it has also become clear
that cell–cell transmission is not unique to deltaretroviruses: both
HIV and the gammaretrovirus murine leukemia viruses (MLV)
can also be transmitted by cell–cell contacts, and this mode of
transmission is more efﬁcient than cell-free virus. Here, we review
what has recently been learned about transmission of HTLV-
1, including observations that cell–cell transmission can occur
between DC and T cells, as well as between T cells. We also review
what has been learned about the precise interactions between
cells required for the infection of the target cells by HTLV-1 and
by other retroviruses during cell–cell transmission, and discuss
how these ﬁnding may relate to the spread of HTLV-1 between
individuals.
THE VIROLOGICAL SYNAPSE
Although the observation that cell–cell contact is important for
HTLV-1 transmission was made soon after the discovery of the
virus, for many years little was known about the mechanism of
cell-to-cell spread of this virus at the cellular level. In 2003, imag-
ing techniques allowed the initial characterization of a speciﬁc
type of cell contact that allows virions from an HTLV-1-infected
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T lymphocyte to be transmitted to an uninfected target cell
(Igakura et al., 2003; Figure 1A). Confocal microscopy studies of
T cells cultured ex vivo from HTLV-1-infected individuals showed
that infected T cells spontaneously form conjugates with unin-
fected T cells. When this occurs, viral Gag and Env proteins and
genomic RNAs are redirected to the point of contact between
the T cells, indicating that viral assembly occurs at the junction
between the infected and uninfected cells. Within 2 h after this
contact, both HTLV-1 viral proteins and genomic RNAs were
observed in the uninfected cell, suggesting that the virus had been
FIGURE 1 | Models of HTLV-1 cell–cell transmission. (A) Virological
synapse.When HTLV-1-infected cells contact uninfected cells, the virological
synapse (VS) is formed by speciﬁc interactions between proteins on the
infected and uninfected cells, and the MTOC (gray circle) is reoriented
toward VS. Viral budding is polarized to the virological synapse, and the
newly budded viruses enter the synaptic cleft formed by the VS, and then
enter the target cells following interactions with the cellular receptors.
(B) Cellular conduits. HTLV-1-infected cells can also transfer virus to
uninfected cells by transient membrane extensions (cellular conduit).
Interactions can occur between conduits on the infected and uninfected
cell, or between cells and conduits (not shown), and particles have been
observed at these contact points, suggesting that these may be a variant
of the VS. (C) Extracellular viral assemblies. Following budding from the
infected cell, the HTLV-1 virus remains associated with the cell within a
matrix containing components of the extracellular matrix (ECM). Upon
contact, these adhesive viral assemblies are rapidly transferred to an
uninfected cell, which they subsequently infect. (D)Trans-infection via
dendritic cells (DCs). DCs capture cell-free HTLV-1, transiently store the virus
in surface-accessible compartments, and then, prior to becoming infected
themselves, transfer the virus to uninfectedT cells. This interaction may
involve membrane extensions of the DCs and/or theT cells, as has been
observed for HIV.
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transmitted to the target cell (Igakura et al., 2003). By analogy to
other previously described specialized junctions, such as neuronal
and immunological synapses, the structure at the junctionbetween
the infected and uninfected cell was named the virological synapse
(VS; Igakura et al., 2003).
Soon after the description of theVS in HTLV-1 transmission, it
was reported that HIV can also be transmitted from an uninfected
to infected T cell via a VS (Jolly et al., 2004) and, as detailed below,
a number of subsequent studies have more fully characterized the
HIV VS. Another retrovirus, MLV, has also been shown to form a
VS between infected and uninfected cells (Sherer et al., 2007; Jin
et al., 2009).
For both these viruses, interactions between the virally encoded
Env proteins and entry receptors are critical for the initial stage of
infection, duringwhich stable interactions are formed between the
cells. For HIV, formation of the VS has been shown to be initiated
by interactions between the surface (SU) envelope glycoprotein
gp120 on the infected T cell and the receptor molecule CD4 on
the target T cell (Jolly et al., 2004; Felts et al., 2010). Similarly,
MLV infection was observed to involve interactions between its
SU (gp70) on ﬁbroblasts expressing viral proteins and the MLV
receptor mCAT-1 on the target cell (Jin et al., 2009). Although
it has not yet been directly examined, there is some evidence
that supports the notion that Env/receptors interactions are also
required to trigger the formation of the HTLV-1 VS. It has been
shown that NRP-1 and Glut1 colocalize at the junction formed
between an HTLV-1-infected T cell and a non-infected target
T cell (Ghez et al., 2006). Moreover, blocking interactions with
HSPGs or NRP-1 on T cells has also been shown to block infec-
tion following cell–cell transmission from HTLV-1-infected DC
(Jones et al., 2008).
For the HIV-1 VS, it has been reported that the initial
Env/receptor interaction between the infected and uninfected cells
is reinforced by interactions mediated by adhesion molecules that
stabilize the junction. These include speciﬁc interactions between
the integrins intercellular adhesion molecule 1 (ICAM-1) and
ICAM-3 and their ligand lymphocyte function-associated anti-
gen 1 (LFA-1; Jolly et al., 2007). Interactions between ICAM-1 and
LFA-1 have also been shown to be critical for formation of the
HTLV-1 VS (Barnard et al., 2005).
These stable contacts between the two cells delineate an intra-
cellular space referred to as the synaptic cleft. Electron tomography
studies revealed the presence of HTLV-1 particles in the synap-
tic cleft between infected and uninfected primary lymphocytes
(Majorovits et al., 2008). Many of the viruses observedwere touch-
ing the membrane of the infected cell, the target cell, or both,
indicating that HTLV-1 is released from the polarized cell into
the synaptic cleft, and is efﬁciently transferred to the target cell.
This is similar to what has been observed for HIV and MLV
during formation of their VS: Gag and Env proteins of these
viruses localize to the point of cell–cell contact, and the viruses
bud into the synaptic cleft (Jolly et al., 2004; Hubner et al., 2009;
Jin et al., 2009).
It seems that the increased efﬁciency of cell–cell transmission
over cell-free transmission reﬂects at least in part a quantitative
advantage, since it allows the polarized release of large numbers
of concentrated particles in close proximity to the target cells.
Consistent with this notion, recent studies using labeled genomes
(Del Portillo et al., 2011) and 3D video microscopy (Hubner et al.,
2009) have shown that cell–cell transmission of HIV via the VS,
but not exposure to cell-free virus, can result in the infection of
target cells by multiple virus particles.
The observation of the redistribution of the Gag and Env
proteins of HTLV and other viruses, followed by the bud-
ding of virus into the VS, suggests that the viral proteins are
being actively transported to the point of contact, which would
likely involve active transport by the cytoskeleton. Consistent
with this, the initial studies of the HTLV-1 VS reported that
talin, an actin-associated cytoskeletal protein involved in cell–
cell interactions, accumulated at the point of contact between
the cells (Igakura et al., 2003). These initial studies also reported
that the microtubule-organizing center (MTOC) was polarized
toward the VS in the HTLV-1-infected cells, but not in the target
cells (Igakura et al., 2003). Disrupting formation of microtubules
was shown to inhibit both the polarization of the MTOC and
the transmission of the HTLV-1 particle to the uninfected cell
(Nejmeddine et al., 2005). Later infectivity studies using HTLV-1-
based single-cycle vectors to quantify transmission between cells
supported the notion that the cytoskeleton plays an important
role in cell–cell transmission: disrupting either actin function or
microtubule formation dramatically reduced the level of infection
(Mazurov et al., 2010).
Subsequent studies have shown that the MTOC also polarizes
in HIV-1-infected cells during VS formation, and that the polar-
ization of the viral proteins involves actin and tubulin (Jolly et al.,
2004, 2007; Chen et al., 2007; Sol-Foulon et al., 2007; Vasiliver-
Shamis et al., 2009). For HIV, it has recently been proposed that
the delivery of viral proteins following the polarization of the
infected cell involves the regulated secretory pathway of CD4+
T cells (Jolly et al., 2011). It was observed that the polarization of
the MTOC is associated with the alignment of organelles involved
in the secretory pathway, that these organelles colocalize with HIV
Env proteins, and that cells with a genetic defect in this path-
way were less efﬁcient at cell–cell transmission of the virus (Jolly
et al., 2011). Because of the other similarities between the HTLV-1
and HIV VS, it seems possible that HTLV-1 could also hijack this
secretory pathway to facilitate cell–cell transmission.
Little is knownabout the fate of HTLV-1 following transmission
across the VS. However, for HIV, a number of recent studies have
provided insight into the steps required for productive infection
following transmission via the VS. Several recent studies support
a model that involves two steps prior to productive infection of
CD4+ T cells. It has recently been observed that, following bud-
ding from the polarized infected cell, immatureHIV viral particles
enter an internal endocytic compartment of the target cells, a step
that has been called cell-to-cell transfer (Bosch et al., 2008; Hubner
et al., 2009; Puigdomenech et al., 2009). The virus then matures,
which allows Env-mediated fusion of the viral and cellular mem-
branes in the endocytic compartment (Dale et al., 2011). Future
work is needed to investigate whether a similar pathway is used by
HTLV-1 following transmission via the VS.
For HTLV-1, the virus-encoded transactivating protein Tax
has been shown to contribute to VS formation and cytoskeletal
polarization in several related ways. Tax upregulates expression
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of ICAM-1 (Tanaka et al., 1995) which, as described above, facil-
itates VS formation by interacting with LFA-1 on the uninfected
cells (Barnard et al., 2005). Tax has been observed to localize to a
region near the point of contact, and there is some evidence that
Tax triggers MTOC polarization by enhancing signaling through
ICAM-1, and possibly other molecules (Barnard et al., 2005; Giam
and Jeang, 2007; Nejmeddine et al., 2009). The importance of Tax
during cell–cell transmission was conﬁrmed in infectivity assays
with HTLV-based vectors: in the absence of Tax, infectivity was
reduced more than a log (Mazurov et al., 2010). This effect was
dependent on the infected cell type (Tax enhanced cell–cell spread
from T cells but not from ﬁbroblasts) and the Env present on
the HTLV-1 core (the infection levels of VSV-G pseudotyped viri-
ons were not increased in the presence of Tax) (Mazurov et al.,
2010). Thus, it appears that Tax plays a role in enhancing interac-
tions between HTLV-1 Env and adhesion molecules as well as by
facilitating the movement of Env and Gag to the VS.
The HTLV-1 protein p8, which is produced upon cleavage of
the auxiliary protein p12, has also been reported to enhance inter-
actions between HTLV-1-infected cells and uninfected cells. The
p8 protein also promotes cell–cell transmission of the virus by
increasing ICAM-1/LFA-1 interactions (Van Prooyen et al., 2010).
This protein colocalizes with and increases clustering of LFA-1 on
the surface of the infectedT cell, which enhances T cell interactions
by facilitating interactions of LFA-1 with ICAM-1 (Van Prooyen
et al., 2010).
TRANSMISSION BY FILOPODIA, NANOTUBES, OR CONDUITS
Previous studies have shown that HIV and MLV can also be
rapidly transferred between infected and uninfected cells via tran-
sientmembrane tethers including ﬁlopodia andnanotubes (Sherer
et al., 2007; Sherer and Mothes, 2008; Sowinski et al., 2008; Nobile
et al., 2009).Viral particles have been observed on the outer surface
of the ﬁlopodia, ﬁnger-like membrane protrusions from cells, that
formed a bridge between the virus-producing cells and the tar-
get cells (Sherer et al., 2007). For nanotubes, which form de novo
between immune cells separating following contact (Onfelt et al.,
2004), viral particles have been observed within the nanotubes,
transferring between the cells (Sowinski et al., 2008; Eugenin et al.,
2009). For both these routes of infection, as for the VS, entry of
the virus into the target cell requires interactions between the viral
Env proteins and the receptors on the uninfected cell (Sherer and
Mothes, 2008; Sowinski et al., 2008).
Recently it has been reported that HTLV-1 can also spread
from an infected to an uninfected T cell by membrane extensions,
which the authors refer to as cellular conduits (Van Prooyen et al.,
2010). Transmission EM studies revealed that, as occurs during
formation of the VS, the HTLV-1 particles are concentrated at the
point of contact between the HTLV-1-infected cell and the tar-
get cell, either between conduits (Figure 1B) or between conduits
and cells (not shown). In addition to its role in enhancing LFA-
1/ICAM-1 interactions, overexpression of the accessory protein p8
in HTLV-1-infected cells was observed to increase the number and
length of these conduits as well as the number of contacts between
infected and uninfected cells (Van Prooyen et al., 2010). The HIV-
1 accessory protein Nef was also shown to induce the formation
of nanotubes or conduits (Xu et al., 2009; Mukerji et al., 2012).
However, in contrast to p8, Nef does not appear to signiﬁcantly
modulate the formation of the VS (Haller et al., 2011).
TRANSMISSION VIA ADHESIVE VIRAL ASSEMBLIES
Transmission of HTLV-1 and other viruses through theVS and the
other cell–cell connections described above involvemembrane-to-
membrane contact, either between two cells in close contact (in the
case of VS) or at a distance (for ﬁlopodia and conduits). Recently
it has been reported that retroviruses can also be transmitted from
cell-to-cell via clusters of particles attached at the surface of the
producing cells.
HTLV-1-infectedCD4+ Tcells have been observed to have clus-
ters of mature viral particles on their surface (Pais-Correia et al.,
2009). These virions are present within a speciﬁc type of matrix
synthesized by the producing cells, which the authors named a
bioﬁlm, that link the virions to the cell surface as well as to each
other (Figure 1C). This viral/cellular network is enriched in spe-
ciﬁc components of the extracellular matrix (ECM), including
HSPGs, agrin, collagen, and the glycan-binding protein galectin-
3. When CD4+ T cells from HTLV-1-infected individuals were
exposed to uninfected CD4+ T cells, these assemblies were quickly
transferred to the target cell (Pais-Correia et al., 2009). The ECM
components were observed to colocalize with viral proteins, indi-
cating that the HTLV-1 was being transferred in the context of
the viral assemblies. Infectivity studies validated the indication
from these imaging studies that these virus assemblies enhanced
cell–cell transmission of the virus: removing these viral assemblies
from the surface of the infected cells, either mechanically or by
treatment with heparin, reduced the number of newly infected
target cells by more than 80% (Pais-Correia et al., 2009).
Studies of MLV-infected ﬁbroblast cell lines have also shown
that virus assemblies on the cell surface can enhance cell–cell
transmission. Newly budded viruseswere observed to remain asso-
ciated with the surface of infected cells and removing heparan
sulfate from the cell surface caused the viruses to detach (Sherer
et al., 2010). As was observed for HTLV-1, MLV particles on the
surface of infected cells are transmitted following contact with
uninfected cells.
Reports that cell–cell transmission of HTLV-1 occurs by VS
and by transfer of extracellular viral assemblies, in studies using
similar techniques on similar cells, raises the question of whether
the different laboratories are observing the same phenomena but
reaching different conclusions, or whether they were truly observ-
ing distinct phenomena. Moreover, as described above, one group
observed evidence of HTLV-1 transmission via both membrane
extensions and VS in the same cocultures of infected and unin-
fected cells (Van Prooyen et al., 2010). It is important to note
that, as elegantly argued in a comment on the study describing
the HTLV extracellular viral assemblies (Jin et al., 2010), different
methods of transmission are not mutually exclusive. It is possible
thatHTLV-1 spreads bothby surface transmissionduring transient
contacts and by polarized assembly and transfer following longer
cell–cell interactions. The authors’ inclusive view about HTLV-1
transmission is likely informed by their laboratory’s own obser-
vations that MLV can be transmitted following polarized viral
assembly and longer term cell–cell interactions via a VS (Jin et al.,
2009) and by longer membrane extensions (ﬁlopodial bridges;
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Sherer et al., 2007; Sherer et al., 2010), as well as by the transfer
of cell-surface bound virus during transient interactions (Sherer
et al., 2010).
HTLV-1 TRANSMISSION BY ANTIGEN-PRESENTING CELLS
In addition to spreading between T cells, HTLV-1 can be transmit-
ted from DCs to CD4+ T cells. In vitro studies have shown that
DC-mediated HTLV-1 infection of T cells can occur in two dif-
ferent ways. In one mode of transmission (cis-infection), the DCs
are infected, and then the de novo produced HTLV-1 is transferred
to the T cells (Jones et al., 2008). In the other (trans-infection),
uninfected DCs capture virus produced by infected T cells, and
transmit the virus to T cells prior to becoming infected themselves
(Figure 1D; Jones et al., 2008; Jain et al., 2009).
Both in vivo and in vitro studies support the notion that trans-
mission to T cells via DCs plays a role in the spread of HTLV
in infected individuals. The two major types of DCs in periph-
eral blood and lymphoid tissues are plasmacytoid DC (pDCs)
and myeloid DCs (myDCs). Studies examining pDCs and myDCs
isolated from the peripheral blood of infected individuals have
shown that they are infected with HTLV-1 (Macatonia et al., 1992;
Knight et al., 1993; Hishizawa et al., 2004). Moreover, pDCs iso-
lated from HTLV-1-infected individuals and cultured ex vivo have
been shown to be able to transmit virus to, and productively infect,
CD4+ T cells (Jones et al., 2008). In addition, primary pDCs and
myDCs isolated from the peripheral blood of uninfected individ-
uals can be infected by cell-free virus in vitro, and these cells can
infect autologous primary CD4+ T cells by the de novo produced
virus (Jones et al., 2008). In vitro generatedmonocyte-derivedDCs
(MDDCs) can also be infected by cell-free HTLV-1, and by cell–
cell interactions with infected CD4+ T cells (Ceccaldi et al., 2006;
Jones et al., 2008; Jain et al., 2009; Lambert et al., 2009; Valeri et al.,
2010; Martin-Latil et al., 2012).
As mentioned above, DC-mediated infection can also occur in
trans, by DCs that bind HTLV-1 and transfer the virus to CD4+
T cells prior to becoming infected themselves. This has been shown
for pDCs and myDCs as well as MDDCs (Jones et al., 2008; Jain
et al., 2009). One protein that has been identiﬁed as important
for efﬁcient transfer of HTLV-1 in trans from MDDCs to T cells
is DC-speciﬁc ICAM-3-grabbing non-integrin (DC-SIGN; Jain
et al., 2009), a lectin previously shown to mediate transfer of HIV
during in trans infection of CD4+ T cells via MDDC. DC-SIGN
expression on uninfected DC has also been shown to promote
transmission of HTLV-1 fromT to DC cells, by enhancing interac-
tions with ICAMs on infected CD4+ T cells (Ceccaldi et al., 2006).
As mentioned above, on the target CD4+ T cell, efﬁcient in trans
transmission of HTLV-1 from infected DCs requires both NRP-1
and HSPG (Jones et al., 2008).
The cell–cell interactions that occur during transmission of
HTLV-1 from DC to T cells, either when transmitted in trans or
from infected cells, have not been well characterized. To date, no
imaging studies examining interactions during the DC-mediated
infection of T cells byHTLV have been published. HIV, like HTLV-
1, can be transmitted to CD4+ T cells via DCs either in trans
following the capture of virus by uninfected DCs (McDonald
et al., 2003) or in cis during cell–cell transmission from infected
DCs to uninfected CD4+ T cells (Burleigh et al., 2006). For the
trans-infection of HIV via MDDCs, early imaging studies showed
that, similar to what occurs during T cell–T cell transmission,
viral particles are concentrated on DC at the site of contact,
CD4 and chemokine co-receptors are recruited to the contact
site on the T cell surface, and virions are transferred to T cells
(McDonald et al., 2003; Arrighi et al., 2004; Turville et al., 2004;
Garcia et al., 2005; Wang et al., 2007). More recent studies using
super resolution light microscopy, ion abrasion scanning electron
microscopy, and electron tomography have revealed that HIV is
transferred from surface-accessible compartments within the DCs
to the T cells, and that these interactions can involve membrane
extensions of the DCs and T cells (Yu et al., 2008; Felts et al., 2010;
Nikolic et al., 2011). Less is known about interactions between
infected DC and CD4+ T cells during the transfer of de novo pro-
duced HIV. One recent study of infected MDDCs observed the
presence of HIV particles on the tips of the majority of the ﬁlopo-
dia. Using real-time imaging, these viral-containing ﬁlopodia were
observed to contact and tether to the CD4+ T cells, and then
reposition and converge to become the DC-T cell viral synapse
(Aggarwal et al., 2012).
Several lines of evidence suggest that cells of the mono-
cyte/macrophage lineage may also be involved in cell–cell trans-
mission of HTLV-1. Like DC, cells of this lineage isolated from
HTLV-1-infected individuals have been reported to be infected
with the virus (Koyanagi et al., 1993) and primary cultures of
monocytes, macrophages, and microglial can be productively
infected in vitro following exposure to cell-free HTLV-1 (Hoff-
man et al., 1992; Koralnik et al., 1992). Macrophages isolated from
breast milk as well as from peripheral blood can also be infected
in vitro by coculture with HTLV-1-infected T cells (de Revel et al.,
1993; Takeuchi et al., 2010). Moreover, breast milk macrophages
can be persistently infected and transformed with HTLV-1,
and these cells can transmit virus to activated T cells (Takeuchi
et al., 2010).
These observations raise the possibility that macrophages play
a role in the persistence of HTLV-1. This has been well docu-
mented for HIV: macrophages can be productively infected with
HIV (Gendelman et al., 1988), and HIV-infected macrophages are
believed to be an important part of the viral reservoir (reviewed
in Le Douce et al., 2010). In contrast to T cells, where the virus
is assembled and released from the plasma membrane, infected
macrophages accumulate HIV in large virus-containing compart-
ment (VCC) inside the cells (Raposo et al., 2002; Nydegger et al.,
2003; Pelchen-Matthews et al., 2003; Sherer et al., 2003; Ono and
Freed, 2004; Deneka et al., 2007). Imaging studies have shown
that HIV released from the VCC can be transmitted to CD4+
T cells via a VS (Gousset et al., 2008; Groot et al., 2008; Ben-
nett et al., 2009). Further studies are needed to determine whether
macrophages play a similar role in the infection and persistence
of HTLV-1.
CELL–CELL INTERACTIONS DURING HTLV-1 TRANSMISSION
BETWEEN INDIVIDUALS
HTLV-1 is transmitted in three ways: from mother to infant, by
sexual contact, and through HTLV-1-infected blood or cellular
blood products (reviewed in Goncalves et al., 2010). This has been
assumed to involve the transfer of HTLV-1-containingT cells in the
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bodily ﬂuids of the infected individuals followed by interactions
with, and infection of, T cells in the recipient. However, the speciﬁc
cell types from either the infected or the uninfected individuals
involved in this transmission have not yet been characterized. In
addition to T cells, a signiﬁcant percentage of pDCs and myDCs
in peripheral blood are infected with HTLV-1 in some individuals
(Hishizawa et al., 2004; Azakami et al., 2009). One study reported
that the HTLV-1 proviral load in pDCs was higher than in PBMCs
from the same individual (Hishizawa et al., 2004). Alongwith stud-
ies demonstrating that HTLV-1 is efﬁciently transmitted to CD4+
T cells via DCs in vitro (Jones et al., 2008) and recent insights into
the cells involved in transmission of HIV and simian immunod-
eﬁciency virus (SIV) described below, these observations support
the notion that cells other than T cells are involved in HTLV-1
transmission between individuals.
MOTHER-TO-CHILD TRANSMISSION
In endemic areas, the primary route of transmission of HTLV-1
is from infected mother to child. The rate of vertical transmis-
sion in endemic populations has been estimated to be between 10
and 25% (Tsuji et al., 1990; Hirata et al., 1992; Nyambi et al., 1996;
Takezaki et al., 1997;Wiktor et al., 1997; Biggar et al., 2006). In the
vast majority of these cases, HTLV-1 infection occurs by ingestion
of breast milk: mother-to-child transmission occurs in less than
5%of womenwho do not breastfeed their children, indicating that
transplacental and perinatal infection are uncommon (Kinoshita
et al., 1987; Caterino-de-Araujo and de los Santos-Fortuna, 1999;
Kashiwagi et al., 2004). Moreover, the risk of HTLV-1 infection
increases with the duration of breastfeeding (Hirata et al., 1992;
Takezaki et al., 1997; Wiktor et al., 1997) and public health poli-
cies in Japan encouraging infected women to avoid breastfeeding
have dramatically reduced the number of mother-to-child infec-
tions (Kashiwagi et al., 2004).Vertical transmission of HTLV-2 also
occurs in this manner: two independent studies saw no evidence
of mother-to-child transmission inwomenwho did not breastfeed
their children (Kaplan et al., 1992; Gallo et al., 1993).
Several lines of evidence indicate that HTLV-1 transmission
via breast milk, like transmission from blood products, involves
infected cells. Cells isolated from the breast milk have been
shown to contain HTLV-1 proviral DNA and epidemiological
studies have shown that the risk of infection in children cor-
relates with the provirus load in these cells (Li et al., 2004).
The fact that cells are sufﬁcient for viral transmission has been
shown in an animal model system: HTLV-1 was transmitted to
non-human primates following oral infection with cells isolated
from the breast milk of HTLV-1-infected women (Kinoshita et al.,
1985). No studies performed to date have examined whether cell-
free HTLV-1 virions are present in the breast milk of infected
women.
The majority of HTLV-1 infections occur in children who have
been breastfed for more than 6 months (Takezaki et al., 1997).
At that time, the majority of the cells in breast milk (>80%)
are T cells; monocytes, macrophages, B cells, and epithelial
cells are also present (Southern and Southern, 1998; Kelly and
Coutts, 2000). Studies with ex vivo cultures of luminal epithelial
cells isolated from the milk of uninfected women revealed that
these epithelial cells can become infected following exposure to
HTLV-1-infected T cells. The HTLV-1-infected epithelial cells can
become transformed, and these transformed cells spontaneously
produce an ECM (Southern and Southern, 1998). Moreover, both
T lymphocytes isolated from peripheral blood and epithelial cells
isolated from the gut were infected following coculture with these
transformed,HTLV-1-infected cells (LeVasseur et al., 1998; South-
ern and Southern, 1998). In light of the more recent studies
characterizing the extracellular viral assemblies described above,
it is interesting to note that the level of infection in this study
was reported to be higher for the T cells cultured with HTLV-1-
infected epithelial cells attached to the ECM than those cultured
with non-adherent aggregates of the same cells.
In addition to T cells and epithelial cells, breast milk macro-
phages also may play a role in transmission: it has recently been
reported that these cells can be infected with HTLV-1 and that a
cell line generated fromHTLV-1-infected breastmilkmacrophages
can transmit virus to primary T cells (Takeuchi et al., 2010).
After the HTLV-1-infected cells enter the digestive tract, infec-
tion would likely involve transfer of HTLV-1-infected cells and/or
cell-freeHTLV-1producedby those infected cells across the epithe-
lium in the oral or gastrointestinal mucosa. This could occur in a
number of different ways, some of which are shown in Figure 2.
HTLV-1-infected cells could be transmitted at places where the
integrity of mucosa is disrupted or where there are gaps in the
epithelium (Figure 2A). It is also possible that HTLV-1-infected
cells could cross intact epithelium: HIV-infected macrophages
have recently been shown to be able to transmigrate across fetal
oral epithelia (Tugizov et al., 2012). Alternatively, the HTLV-1-
infected cells could attach to the apical side of the epithelial cells,
infect the cells by cell–cell transmission of the virus, and the
newly produced viral particles could bud from the basal surface
(Figure 2B). This model is supported by in vitro studies show-
ing that HTLV-1-infected T cells can adhere to the microvilli of
a monolayer formed by an intestine-derived epithelial cell line,
that a large number of viral particles are released into the space
between the cells, and that the epithelial cells became infected
(Zacharopoulos et al., 1992). Another way that the cell-free HTLV-
1 virions produced by infected cells could be transmitted through
an intact epithelial barrier is by being taken up by a vesicle on
the apical surface of an epithelial cell and transported to and
released from the basal side (Figure 2C). HTLV-1 has recently
been shown to be capable of crossing an epithelial barrier by this
process, which is referred to as transcytosis: virus produced from
infected T cells was transported across a tight epithelial barrier
in an in vitro model of human intestinal cells (Martin-Latil et al.,
2012). Moreover, the transmitted virus was able to infect human
DCs located immediately below the epithelial barrier (Martin-Latil
et al., 2012). HIV-1 has also been shown to be capable of crossing
intact oral and intestinal epithelial barriers by transcytosis and to
be capable of infecting DCs, macrophages, and CD4+ T cells on
the other side of those barriers in both ex vivo studies using tis-
sue explants and in vitro studies (Bomsel, 1997; Alfsen et al., 2005;
Tugizov et al., 2012).
In the model of infection just described, the cells in the child
would become infected after the HTLV-1 crossed the oral or gas-
trointestinal mucosa, either as an infected cell or as a cell-free
particle. It is possible that HTLV-1-infected cells, either T cells
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FIGURE 2 | Schematic of several possible pathways for HTLV-1
transmission via breast milk. HTLV-1-infected cells present in breast milk
(T cells, macrophages, and/or epithelial cells) could transmit the virus across
the oral or gastrointestinal mucosa in several ways. The HTLV-1-infected cells
could cross the barrier at positions where the mucosa are disrupted (A) or by
transmigration across the epithelial barrier (not shown). HTLV-1 could then
be passed by cell–cell transmission to the target cells present in the lamina
propia (T cells, macrophages, DC/Langerhans) or in the draining lymph nodes.
Alternatively, the HTLV-1-infected cells could infect epithelial cells by cell–cell
transmission of the virus (B), and these productively infected epithelial cells
could either directly infect target cells in the lamina propia, or produce virus
that is captured by a DC or other APC. Following capture, HTLV-1 could be
transmitted to susceptible cells either in the lamina propia or lymph nodes.
The virus produced by HTLV-1-infected cells could also by transmitted without
infecting epithelial cells by transcytosis (C), be captured by APC, and
subsequently used to infect target cells.
or antigen-presenting cells (APCs), could then infect resident
T cells immediately after the barrier was crossed. T cells, DCs,
and macrophages have all been observed to be present in the oral
mucosa of infants (Tugizov et al., 2012).
If cell-free virus crossed the barrier, DC or other APCs could
either become infected or capture HTLV-1. These APCs could
transfer the virus to either resident T cells or T cells present in sec-
ondary lymphoid organs after exiting the mucosa and migration.
It is interesting to note that the basal surface of the epithelial cells
is connected to the basement membrane, which contains compo-
nents of the ECM present in the extracellular viral assemblies. It
is possible that these could interact with the cell-free particles to
enhance transmission to the target cells.
SEXUAL TRANSMISSION
Theother natural route of infectionof HTLV-1 is by sexual contact.
Although early studies suggested thatmale-to-female transmission
of HTLV-I infectionwasmuchmore frequent than female-to-male
transmission, later prospective studies have shown that this dif-
ference is not as dramatic as previously believed (Roucoux et al.,
2005). As is the case for transmission from mother to child, little
is known about what infected cells are transmitted from men or
womenwithHTLV-1, or what cells are the initial targets in the pre-
viously uninfected individual. Although no studies performed to
date have examinedwhich cells are infected in the semen of HTLV-
1-infected men, semen in healthy men contain several different
cell types including CD4+ T cells and macrophages (reviewed in
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Anderson et al., 2010), suggesting that one or both of these cells
are the source of the virus. In regard to female-to-male trans-
mission, HTLV-1-infected cells have been detected in cervical
secretions of infected women (Belec et al., 1996; Zunt et al., 2002),
although the infected cell types were not identiﬁed. CD4+ T cells
can be detected in cervicovaginal secretions from healthy women,
although the numbers are very low. However, the number of CD4+
T cells is increased in cervicovaginal secretions with certain infec-
tions; this is consistent with the observation that detection of
HTLV-1-infected cells in cervical secretions was associated with
inﬂammation of the uterine cervix (Zunt et al., 2002).
Sexual transmission of HTLV-1 would presumably require
entry through mucosal barriers in the female and male genital
tracts. As during transmission by breastfeeding, the virus could
be transmitted where lesions disrupt the mucosa, by infection of
the epithelium or by transcytosis across epithelial cells. Female-
to-male transmission is higher in men with syphilis or a history
of penile sores or ulcers (Murphy et al., 1989), consistent with
the notion that disrupting the epithelium increases transmission.
Infection of a cervix-derived epithelial line following exposure to
HTLV-1-infected T cells has been shown in vitro (Zacharopou-
los et al., 1992), and HTLV-1 has been associated with carcinoma
of the cervix (Strickler et al., 1995), suggesting that viral infec-
tion of epithelium or other cells in the cervix may play a role in
male-to-female spread.
Although the mechanism of this transmission has not been
examined for HTLV, mucosal entry of HIV and SIV in the genital
tracts have been well characterized by in vitro studies of puriﬁed
cell populations, ex vivo studies using human explants, and in vivo
studies in macaques and humanized mice (reviewed in Hladik
and McElrath, 2008; Ganor and Bomsel, 2011; Kaushic, 2011).
These studies have shown that HIV can be transmitted across the
epitheliumby all of themethods described above: infected seminal
cells, or virus produced by those cells, have been shown to cross
through gaps in the epithelium, by infecting the epithelium, or by
transcytosis.
Once viruses have crossed the mucosal barriers, as with infec-
tion via breast milk, they can infect DCs, macrophages, or T cells.
ForHIV, a number of studies suggest thatAPCs capture the viruses
and transfer them to T cells. For example, study performed with
a model for HIV-1 female-to-male transmission using foreskin
explants observed that virus-infected cells form aVS with the api-
cal side of foreskin keratinocytes and that HIV-1 subsequently
budding from the basal side is captured by Langerhan cells (LC),
a type of DC. LC then migrate to the epidermis–dermis inter-
face and transfer the virus to T cells (Ganor et al., 2010). Ex
vivo human organ culture systems for male-to-female transmis-
sion have shown that intraepithelial vaginal LCs can capture HIV
and that these cells can productively infect T cells (Hladik et al.,
2007; Ballweber et al., 2011).
TRANSMISSION BY BLOOD
As discussed in the introduction, HTLV-1 can be transmitted by
transfusion of whole blood or blood products containing cells.
Transmission by blood also occurs during the sharing of needles
by intravenous drug users. Unlike the naturalmethods of infection
described above, transmission via contaminated blood does not
require transmission across amucosal barrier. Consistentwith that
notion, transmission via blood is efﬁcient: one prospective study
showed seroconversion of 44% of recipients after a single expo-
sure to HTLV-1-infected cellular blood products (Manns et al.,
1992). Because of the lack of a barrier, this method of transmis-
sion could involve direct transmission of HTLV-1 from the cells of
the infected individual to target cells in the previously uninfected
individual. Since the virus is predominantly found in T cells in
peripheral blood, this type of transmission could occur during
direct interactions between T cells by the methods that have been
described for in vitro T cell–T cell transmission: viaVS, by transfer
of extracellular viral assemblies, or other methods. Since myDCs
and pDCs from peripheral blood of asymptomatic individuals are
infectedwithHTLV-1 (Hishizawa et al., 2004; Azakami et al., 2009)
transmission from DC to T cells may also occur.
Individuals who acquireHTLV-1 by blood transfusion aremore
likely to develop the chronic inﬂammatory disorder HAM/TSP
(Osame et al., 1990), while individuals who acquire the virus dur-
ing breast feeding are more likely to develop the T cell malignancy
ATL (Kakuda et al., 2002). While this could reﬂect a number of
other factors (including age of infection, amount of virus acquired
during transmission, and immune response), it has been suggested
that these different methods of infection result in different popu-
lations of infected cells, which in turn inﬂuences which disease a
given infected individual is more likely to develop.
ESTABLISHMENT OF HTLV-1 INFECTION
As described in the introduction, it is believed that infection of an
individual with HTLV-1 occurs in two stages. The virus is thought
to initially spread from T cell to T cell, primarily between CD4+
T cells, and later to persist by clonal expansion of infected cells.
Although nearly all studies of HTLV-1 performed to date have
focused on studies of T cells from peripheral blood, it would seem
likely that at least some of this spread would occur in the lymph
nodes, where the concentration of the T cells is higher and the
T cells are highly motile. The notion that a signiﬁcant number of
HTLV-1-infected cells are present outside the peripheral blood is
supported by observations of a strong immune response (HTLV-1-
speciﬁc T cells and antibodies) in chronically infected individuals,
even when no virus or virus-expressing cells can be detected in the
peripheral blood.
One recent study of HIV transmission provides a model for
how the observations of cell–cell transmission via VS observed for
HTLV-1 and HIV-1 in vitro might be relevant to in vivo transmis-
sion in lymph nodes (Llewellyn et al., 2010). In lymphoid organs,
such as lymph nodes, T cells are highly motile and adopt an elon-
gated or polarized morphology. When HIV-1-infected polarized
T cells were examined, Gag was found to localize to a rear end pro-
trusion known tomediate contact with other cells called a uropod.
The uropods preferentially form contacts with target cells, and
these uropod-mediated contacts eventually form a VS (Llewellyn
et al., 2010). It seems possible that, soon after an individual is
infected with HTLV-1, the virus spreads between T cells in the
lymph nodes using a similar mechanism.
It is also possible that DCs or other APC cells contribute to
the cell–cell spread during this early stage of transmission. DCs
can be highly mobile and, as described above, are infected at a
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signiﬁcant level in many individuals with HTLV-1. This notion
that virus may be passed from T cells to DC and then back to
T cells is also supported by the in vitro observations that both
DCs can be infected by HTLV-1-infected T cells and T cells can be
infected by HTLV-1-infected DC.
Another possible reservoir for HTLV-1 is human CD34+
hematopoietic progenitor/stem cells (HP/HSCs). HTLV-1 can
infect these cells when cultured ex vivo, and the proviral genome
is maintained when the cells are differentiated down several
lineages, including T cells and monocyte/macrophage lineages
(Feuer et al., 1996). Moreover, a signiﬁcant number of SCID mice
in which hematopoiesis is reconstituted with HTLV-1-infected
CD34+ HP/HSCs develop lymphoma similar to ATL (Banerjee
et al., 2010). CD34+ HP/HSCs isolated from infected individu-
als have been reported to contain HTLV-1 sequences (Banerjee
et al., 2010), and, in one case, transmission of HTLV-1 occurred
following allogeneic BM transplantation (Kikuchi et al., 2000).
CONCLUSIONS AND PERSPECTIVES
Insights gained in the last 10 years have dramatically changed
our understanding about how HTLV is transmitted between cells.
The long held beliefs that efﬁcient transmission of HTLV-1 and
HTLV-2 requires interactions between an infected and an unin-
fected T cell, and that this mode of transmission distinguishes
these viruses from other retroviruses, no longer appears to be
the case. While a decade ago little was known about the inter-
actions between cells required for HTLV-1 transmission, recent
imaging studies have identiﬁed some of the components of the
infected cell, the uninfected cell, and the virus that facilitate dif-
ferent types of cell–cell transmission. The more detailed studies of
HIV-1 cell–cell transmission and other retroviruses have provided
additional clues about how HTLV-1 may be transmitted. These
studies, along with in vitro studies of infectivity, have revealed that
T cells can be infected by cell–cell transmission from infected non-
T cells as well as T cells. They have also demonstrated that cell–cell
transmission of HTLV-1 and HIV to a target cell can occur via an
uninfectedAPC that has captured viral particles, as well as from an
infected cell.
These studies suggest that the mechanism of transmission
between individuals, and within newly infected individuals prior
to the clonal expansion that characterizes chronic infection by
HTLV-1, differs from the current dogma that cell–cell transmission
of HTLV-1 only involves interactions between T cells. Observa-
tions that macrophages and epithelial cells isolated from breast
milk can be infected and transformed with HTLV-1 suggest that
transmission via breast milk might involve these cells as well as
T cells. The fact that HTLV-1-infected DCs are present in the
peripheral blood of infected individuals, and that T cells are efﬁ-
ciently infected byDC in vitro, suggests thatDCs or otherAPCplay
a role in HTLV-1 transmission between individuals, and/or during
the initial spread of infection in an individual. This is supported
by the large number of studies indicating that DC and other APC
play a role during mucosal entry of HIV and SIV.
Despite our recent advances, there are many aspects of HTLV-1
transmission that remain poorly understood. Nothing is known
about whether productive infection following cell–cell transmis-
sion of HTLV-1 occurs following endocytosis of the virus by the
target cell and/or by fusion at the cellular surface. Since cell-free
HTLVhas been shown to efﬁciently bind and enter primary T cells,
it is unclear whether the block to stable infection reﬂects uptake
by a non-productive pathway, restriction by intracellular antiviral
factors, a negative effect of viral expression in the cells, or other
factors. Although one can speculate (as we have in the previous
section) aboutwhat cells are involvedduring transmissionbetween
individuals by mucosal and parenteral routes based on studies of
lentiviral transmission, only a few, limited studies have been per-
formed on ﬂuids from HTLV-1-infected individuals or with ex
vivo cultured cells and tissues to address this directly. In addition,
once an individual is infected with the virus, it is unclear where,
or between what cell types, the virus initially spreads prior to
clonal expansion of the infected T cells, and whether HTLV-1 per-
sists in reservoirs outside the peripheral blood during the chronic
stage of infection. Future studies investigating these and other
aspects of HTLV transmission and persistence will be important
for developing therapeutics to block initial infectionwith the virus,
as well as to reduce the level of cells containing the virus in infected
individuals.
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